Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms.

about

Modelling of ciprofloxacin killing enhanced by hyperbaric oxygen treatment in Pseudomonas aeruginosa PAO1 biofilms.

Item

http://www.wikidata.org/entity/Q55317638

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Modelling of ciprofloxacin kil ...... onas aeruginosa PAO1 biofilms.

@en

Modelling of ciprofloxacin kil ...... onas aeruginosa PAO1 biofilms.

@nl

type

Item

label

Modelling of ciprofloxacin kil ...... onas aeruginosa PAO1 biofilms.

@en

Modelling of ciprofloxacin kil ...... onas aeruginosa PAO1 biofilms.

@nl

prefLabel

Modelling of ciprofloxacin kil ...... onas aeruginosa PAO1 biofilms.

@en

Modelling of ciprofloxacin kil ...... onas aeruginosa PAO1 biofilms.

@nl

P1476

Modelling of ciprofloxacin kil ...... monas aeruginosa PAO1 biofilms

@en

P2093

Peter Alexander Vistar Gade

http://www.w3.org/2001/XMLSchema#string

Terkel Bo Olsen

http://www.w3.org/2001/XMLSchema#string

P2860

Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen

Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients

Cystic fibrosis

Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa

Pseudomonas aeruginosa biofilms in cystic fibrosis

Distinguishing Antimicrobial Models with Different Resistance Mechanisms via Population Pharmacodynamic Modeling

Lung infections associated with cystic fibrosis.

Nitrous oxide production in sputum from cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infection

Polymorphonuclear leukocytes restrict growth of Pseudomonas aeruginosa in the lungs of cystic fibrosis patients.

Physiological levels of nitrate support anoxic growth by denitrification of Pseudomonas aeruginosa at growth rates reported in cystic fibrosis lungs and sputum.

P304

e0198909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0198909

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-06-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29902223

http://www.w3.org/2001/XMLSchema#string

P921

Pseudomonas aeruginosa

P932

6002088

http://www.w3.org/2001/XMLSchema#string